Company Profiles

Print



HaHarash St. 34
Hod Hasharon 45800
Israel

Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world. Our product offering categories include heart and respiratory health, infectious diseases and women's health. We continue to focus our research on conditions that affect millions of people around the world - diseases like Alzheimer's, diabetes and cancer - while expanding our strengths in areas like vaccines and biologics. We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them. At Merck, we're applying our global reach, financial strength and scientific excellence to do more of what we're passionate about: improving health and improving lives.
Merck. Be well.
 


Novartis Pharma Services AG,
P.O. Box 7759
IL-49250 Petach Tikva
ISRAEL
Phone +972 3 9201111
Fax +972 3 9229244
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number one in sales (57.9 billion US$) among the world-wide industry in 2013. Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide. Our global Pharmaceuticals portfolio includes more than 50 key marketed products, many of which are innovative leaders in their therapeutic areas such as: Cardio metabolic, Retina, Respiratory, Neuroscience, oncology, Immunology and Dermatology.



Zarchin 13 street Ra'anana
P.O 4070.
4366241
Israel
Tel: 073-2226099
Fax: 09-7406527
http://www.astrazeneca.co.il/
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.
We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world's most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
We are active in over 100 countries & invest over $4 billion in R&D each year with 14 major R&D centers in 8 countries.
AstraZeneca Israel was established in 2007 as official representative of the international company.
For more information please visit the company website: www.astrazeneca.com



P.O.Box 2160
Herzelia, Israel
Tel: 09-9606234
Fax: 09-9576001
Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.
Our mission
We make medicines that help people live longer, healthier, more active lives.
Our values
Integrity, excellence, respect for people
Our vision
We will make a significant contribution to humanity by improving global health in the 21st century.




Pfizer Pharmaceuticals Israel Ltd.
P.O. Box 12133, 9 Shenkar St.
Herzliya Pituach, Israel 46725
Tel: 972-9-9700500,
Fax: 972-9-9700501
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.
Our diversified global health care portfolio includes biologic and small molecule medicines and vaccines, as well as many of the world's best-known consumer products.
Consistent with our responsibility as the world's leading Biopharmaceutical Company, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.



89 Medinat Ha-Yehudim St.
P.O. Box 4124|
Hertzliya-Pituach
Israel

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 142 affiliates and a total of more than 47,400 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Taking social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative "Making more Health" and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.

In 2013, Boehringer Ingelheim achieved net sales of about 14.1 billion euros. R&D expenditure corresponds to 19.5% of its net sales.

For more information please visit
www.boehringer-ingelheim.com


HaTa'as St 20
Kefar Saba, Israel
Tel: 09763047
Fax: 097630455
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 41,500 employees in 75 countries, and markets its products in more than 180 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).


Sanofi Israel, 10 Beni Ga`on St., P.O.B 8090 Netanya 4250499, Israel
Tel: +972 9 8633700 Fax: +972 9 8851444
www.sanofi.co.il

Sanofi Israel is an affiliate of Sanofi, a leading global healthcare company with a diverse and comprehensive portfolio. Sanofi Israel is very well established in the Israeli health care community and holds a leading position in the pharmaceutical sector;

Sanofi Israel has a strong legacy of products focusing on the following therapeutic areas:
Diabetes
Thrombosis/Blood and Circulation
Oncology
Cardiovascular
Nephrology
Urology
Consumer Health Care/OTC

Scientifically supported by a regional medical and marketing staff based in the new industrial area of Netanya, Sanofi provides patients and healthcare professionals in Israel with efficient and effective therapeutic responses to diseases in our major therapeutic areas. The Israel affiliate also incorporates a highly professional Clinical Operations Unit.









Medison is Israel's leading marketing group, representing innovative niche healthcare solutions companies such as Biogen Idec., Amgen, Shire, Boston Scientific and Ipsen. Employing a comprehensive approach to sales and service, Medison supplies and maintains long-standing relations with HMOs (Health Maintenance Organizations), local medical centers and physicians. Backed by three generations of experience in the healthcare industry since 1937, Medison is uniquely qualified to provide the complete spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli, Romanian and Slovakian healthcare markets.
Medison has offices and active in Israel and Romania.

Medison Romania
S.R.L
Bd. Iancu De Hunedoara 54 B
Avantgarde Office Building Floor 6
1 District, 011745, Bucharest, Romania
Tel: +40-31-7104035
Fax: +40-31-7104032
Email: office@medison.com.ro
Medison Pharma
10 Hashiloach St. P.O.B 7090
Petach Tikva, 49170, Israel
Tel: 972.3.925.0250
Fax: 972.3.922.5740


Bayer Israel Ltd.
36 Hacharash Street
Hod Hasharon, Israel, 45240
Tel. +972 9 7626700
Fax +972 9 7626730
Web:
http://www.bayer.com/
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56,000 employees (Dec 31, 2013) and is represented in more than 100 countries.



GlaxoSmithKline (GSK)
25 Basel Street
P.O. Box: 10283,
Petach-Tikva,4900202, Israel
Tel: 03-9297100
Fax: 03-9297101
For medical information il.medinfo@gsk.com
GSK is one of the world´s leading research based pharmaceutical and healthcare companies with a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.





J-C Health Care Ltd.
Shefayim Commercial Bldg.
Kibbutz Shefayim, Israel, 6099000
www.janssen.co.il
fax: 09-9593838
phone: 09-9591100
The Janssen Pharmaceutical Companies of Johnson & Johnson
For more than 75 years, Janssen has been helping improve health around the world. From early discovery to distribution, patient access and education, we continuously search for ways to deliver quality and value.
Together, we share a vision of providing innovative solutions that bring value to people, healthcare professionals and health systems around the world. Driven by our commitment to patients, we deliver products and services that offer hope and a healthier life to people throughout the world



Lundbeck Israel
Hashalom 4, Tel Aviv
Tel: 03-9100100
Fax: 03-9100117
www.lundbeck.co.il

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain disease. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at diseases such as depression and anxiety, psychotic disorders, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.
Furthermore, we operate for medical education in the community and for increasing the awareness to treatment options and to the patients' different needs by giving tools and knowledge
 


Rafa is a leading pharmaceutical company in Israel that markets, manufactures and distributes prescription (Rx) and over-the-counter (OTC) medicines, mainly proprietary formulations as well as generic formulations, and consumer health products.

With a history of over 75 years, Rafa is a trusted partner of some of the leading pharmaceutical companies, such as Galdrema, Takeda, Dr. Falk Pharma, Helsinn, and more

Rafa is part of the privately owned international group of independent associated pharmaceutical companies - the Purdue / Mundipharma / Napp group. The group covers the entire global pharmaceutical market where companies develop and market a broad range of therapeutic solutions, and operate under safety, development and manufacturing global standards.

 


Teva Pharmaceutical Industries Ltd,
1 Hateena St.
P.O. Box 975,
Modiin Region Industrial Park,
Shoham 60850,
Israel

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world's largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com